RIDR-PI-103, CAS [[2581114-71-6]]

Produktübersicht

• Artikelname: RIDR-PI-103, CAS [[2581114-71-6]]
• Artikelnummer: MCE-HY-144876
• Hersteller Artikelnummer: HY-144876
• Alternativnummer: MCE-HY-144876-5MG,MCE-HY-144876-10MG,MCE-HY-144876-25MG,MCE-HY-144876-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

RIDR-PI-103 is a reactive oxygen species (ROS)-induced agent release proagent with a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103). Doxorubicin and RIDR-PI-103 shows a synergistic effect in MDA-MB-361 and MDA-MB-231 cells to inhibit cancer cell proliferation[1][2].

Produkteigenschaften

• Molekulargewicht: 511.53
• Reinheit: 98.02
• CAS Nummer: [2581114-71-6]
• Formel: C27H25N7O4
• Target-Kategorie: Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound